Silexion Therapeutics Corp (SLXN)
Biological Products, (No Diagnostic Substances) · Healthcare · $8M
Intrinsic Value (Consensus)
$0.00
Current Price
$2.71
Margin of Safety
0%
At Fair Value
Value: $0
Price: $3
Valuation Model Estimates
Current Price: $2.71
DCF (Discounted Cash Flow)
$90.88
Graham Number
$12.96
Earnings Power Value
$86.99
Relative Value (P/E)
$179.20
Dividend Discount Model
Not applicable
—
Consensus Value
$0.00
Model Assumptions
Discount Rate
10.3%
Growth Rate
2.0%
Terminal Growth
2.5%
Risk-Free Rate
4.3%
Discount rate derived from CAPM (risk-free rate + beta × market risk premium). Growth rate based on trailing earnings growth, capped at 20%.
Health Score
F
33
Profitability
10/25
Strength
7/25
Valuation
12/25
Growth
4/25
Financial Health Signals
Negative return on equity — company is losing money on shareholder capital
Negative free cash flow — company is burning cash
Key Financials
- EPS (TTM)
- $8.96
- EPS (Forward)
- $9.14
- Book Value
- $0.83
- P/E Ratio
- 20.0
- Forward P/E
- 19.6
- PEG Ratio
- —
- ROE
- -457.6%
- Debt/Equity
- —
- Revenue Growth
- N/A
- Earnings Growth
- 2.0%
- Dividend Yield
- N/A
- Beta
- 1.00
Similar Stocks (Healthcare)
ABEOAbeona Therapeutics ...
$37.06+300%
ABUSArbutus Biopharma Co...
$18.93+300%
ADVBAdvanced Biomed Inc....
$26.66+300%
AGENAgenus Inc.
$20.19+300%
ATRAAtara Biotherapeutic...
$41.43+300%
Data last updated: 2026-06-16
Source: Yahoo Finance